# Evaluation of Resynchronization Therapy for Heart Failure (EARTH)

> **NCT00901212** · PHASE4 · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 120 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Device programming

## Key facts

- **NCT ID:** NCT00901212
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00901212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00901212, "Evaluation of Resynchronization Therapy for Heart Failure (EARTH)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00901212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*